Systems and Methods for the Detection of Hydroxychloroquine-Mediated Cardiotoxicity
AssigneeMayo Foundation for Medical Education and Research
InventorsGeoffrey B. Johnson, Ian C. Chang, Martha Grogan, John P. Bois, Melanie C. Bois, Joseph J. Maleszewski
Life of this patent
Estimating the term…
Abstract
A method for detecting hydroxychloroquine-mediated cardiotoxicity in a subject. The method can comprise administering a radiotracer to the subject and acquiring an image to detect the presence or absence of hydroxychloroquine-mediated cardiotoxicity in the subject. If cardiotoxicity is found to be present, the method can comprise a further step of determining an extent of the cardiotoxicity in the subject.
Claims20
A method for detecting hydroxychloroquine-mediated cardiotoxicity in a subject, the method comprising:
- administering a radiotracer to the subject;
- acquiring an image to detect the presence or absence of hydroxychloroquine-mediated cardiotoxicity in the subject.
A system for detecting hydroxychloroquine-mediated cardiotoxicity in a subject, the system comprising:
- an injector configured to administer a radiotracer to the subject;
- an imaging system configured acquire an image, wherein the image provides information about the presence or absence of hydroxychloroquine-mediated cardiotoxicity in the subject.
Dependencies are inferred from the claim text.